Dr. Jason Kirby, DO, MBA, DFASAMMedical Director/Board Certified Addiction Medicine Specialist at PursueCare Hepatitis C (HCV) and HIV remain significant public health concerns in the U.S., particularly within the substance use disorder (SUD) community. These infections frequently co-occur, with rates substantially higher among individuals with...

A Year of Hope, Healing, and Growth As we look back on 2024 and embrace the holiday season, I want to extend my heartfelt gratitude for your unwavering support of PursueCare’s mission. Together, we are addressing one of the most pressing challenges in healthcare—providing compassionate,...

December 5, 2024 MIDDLETOWN, CT—PursueCare, virtual addiction treatment provider, announced today that Dr. Jason Kirby, DO, MBA, DFASAM, Medical Director, has been awarded the 2025 Distinguished Fellow of the American Society of Addiction Medicine (ASAM) designation. This prestigious recognition underscores Dr. Kirby’s commitment to advancing...

November 1, 2024 MIDDLETOWN, CT—PursueCare, an innovative leader in virtual addiction treatment, will join a panel of industry experts to discuss the pressing need to address regulations impacting substance use disorder (SUD) treatment at the upcoming Behavioral Health Tech (BHT 2024) Conference. Held at the...